Abbisko Therapeutics is a drug company dedicated to innovative drug research and development.
Abbisko Therapeutics is a drug company dedicated to innovative drug research and development. The company is founded by a group of seasoned drug hunters with rich research and managerial experience in top pharmaceutical companies globally and in China.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 7, 2021 | Series D | $123M | 1 | — | — | Detail |
Mar 25, 2020 | Series C | $70M | 1 | — | — | Detail |
Mar 21, 2019 | Series B | $42M | 1 | — | — | Detail |
Feb 7, 2017 | Series A | $28M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Lilly Asia Ventures | — | Series D |